Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous clinicopathologic entity accounting for 30% of non-Hodgkin's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results